CIK 0000939767 · Large accelerated filer
EXELIXIS, INC.
Sign in to watch- Ticker
- EXEL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Jan 1
- Incorporated
- DE
- Entity type
- operating
- EIN
- 043257395
- Phone
- 6508377000
- Business address
- 1851 HARBOR BAY PARKWAY, ALAMEDA, CA, 94502
- Former names
- EXELIXIS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-15 | Senner Christopher J. EVP and CFO | Shares withheld for taxes | −35,870 | $43.92 | $1.6M | 1,006,709 |
| 2026-02-15 | Haley Patrick J. EVP, Commercial | Shares withheld for taxes | −31,483 | $43.92 | $1.4M | 449,722 |
| 2026-02-15 | MORRISSEY MICHAEL President and CEO | Shares withheld for taxes | −120,390 | $43.92 | $5.3M | 1,829,945 |
| 2026-02-15 | Aftab Dana EVP, Research and Development | Shares withheld for taxes | −26,485 | $43.92 | $1.2M | 706,617 |
| 2026-02-15 | Aftab Dana EVP, Research and Development | Shares withheld for taxes | −12,720 | $43.92 | $559K | 693,897 |
| 2026-02-15 | Hefti Brenda SVP and General Counsel | Shares withheld for taxes 10b5-1 | −5,430 | $43.92 | $238K | 115,181 |
| 2026-02-13 | Senner Christopher J. EVP and CFO | Sale | −34,278 | $43.00 | $1.5M | 1,042,579 |
| 2026-02-13 | MORRISSEY MICHAEL President and CEO | Option exercise | +494,700 | $21.31 | $10.5M | 2,319,941 |
| 2026-02-13 | MORRISSEY MICHAEL President and CEO | Shares withheld for taxes | −369,606 | $43.92 | $16.2M | 1,950,335 |
| 2026-02-13 | MORRISSEY MICHAEL President and CEO | Option exercise · Option (right to buy) | −494,700 | 0 | ||
| 2026-02-13 | Eckhardt Sue Gail Director | Sale 10b5-1 | −3,856 | $43.79 | $169K | 17,524 |
| 2026-02-13 | Oliver Bob Director | Option exercise | +9,088 | $19.28 | $175K | 51,370 |
| 2026-02-13 | Oliver Bob Director | Sale | −9,088 | $43.61 | $396K | 42,282 |
| 2026-02-13 | Oliver Bob Director | Sale | −21,162 | $43.90 | $929K | 21,120 |
| 2026-02-13 | Oliver Bob Director | Option exercise · Option (right to buy) | −9,088 | 12,118 | ||
| 2026-01-15 | MORRISSEY MICHAEL President and CEO | Grant or award | +548,073 | 1,964,765 | ||
| 2026-01-15 | MORRISSEY MICHAEL President and CEO | Shares withheld for taxes | −139,524 | $45.23 | $6.3M | 1,825,241 |
| 2026-01-15 | Aftab Dana EVP, Research and Development | Grant or award | +119,578 | 760,356 | ||
| 2026-01-15 | Aftab Dana EVP, Research and Development | Shares withheld for taxes | −27,254 | $45.23 | $1.2M | 733,102 |
| 2026-01-15 | Haley Patrick J. EVP, Commercial | Grant or award | +139,508 | 513,537 |
Page 4 of 10 · 192 trades